Pregledni rad

https://doi.org/10.21860/medflum2019_218809

A review on the current status of retinal prostheses (bionic eye)

Goran Pelčić ; Klinika za oftalmologiju,Klinički bolnički centar Rijeka, Rijeka, Hrvatska
Ivan Brumini ; Katedra za anatomiju i fiziologiju, Zdravstveno veleučilište Zagreb, Zagreb, Hrvatska
Tea Čaljkušić-Mance ; Klinika za oftalmologiju,Klinički bolnički centar Rijeka, Rijeka, Hrvatska
Zvjezdana Alpeza-Dunato ; Klinika za oftalmologiju,Klinički bolnički centar Rijeka, Rijeka, Hrvatska
Ivana Crnković ; Katedra za fizioterapiju, Zdravstveno veleučilište Zagreb, Zagreb, Hrvatska
Martina Brumini ; Dom zdravlja Primorsko-goranske županije, Čabar, Hrvatska

Sažetak

Argus® II, the first retinal prosthesis is approved for the treatment of patients with retinal pigmentosis. 2011 has received the CE (European Committee) designation and 2013 FDA (Food and Drug Administration) Approval. Retinal prosthesis provides a stable, safe and long-lasting retinal stimulation. The improvement of vision with retinal prosthesis depends on the improvement of the visual resolution, development of the correct neural form for imaging and improvement of the biological compatibility of the device to ensure durability. Once the theme of folklore and science fiction, the idea of returning sight to blind people today is approaching reality.

Ključne riječi

retinal prosthesis; retinitis pigmentosa; visual prosthesis

Hrčak ID:

218809

URI

https://hrcak.srce.hr/218809

Datum izdavanja:

1.6.2019.

Podaci na drugim jezicima: hrvatski

Posjeta: 2.232 *